Long-term stability of early Class III treatment: evidence and new challenges (Online, 10 November 2026)

This WFO Continuing Education webinar examines the long-term outcomes and stability of early Class III orthodontic treatment, addressing key clinical questions that remain controversial in contemporary practice. The presentation explores whether rapid maxillary expansion combined with facial mask therapy (RME/FM) produces stable results over extended periods, and identifies patient-related factors that influence treatment longevity. A significant focus involves the application of artificial intelligence and machine learning to predict craniofacial growth patterns in untreated Class III subjects, offering clinicians new tools for treatment planning and prognosis.

The webinar begins by analyzing growth patterns in untreated Class III patients, establishing the scientific foundation for early intervention during critical developmental phases. Attendees will learn how AI technology can predict long-term craniofacial growth trajectories in these patients, enabling more informed clinical decision-making. The presentation then compares long-term effects of RME/FM therapy against untreated Class III controls, with particular emphasis on mechanisms that control mandibular growth and limit unwanted skeletal changes.

Treatment timing emerges as a crucial variable, with the presentation contrasting outcomes in prepubertal versus pubertal patients, and examining differences between early prepubertal and late prepubertal treatment initiation. Pre-treatment craniofacial features that predict successful long-term outcomes will be illustrated, allowing clinicians to identify patients most likely to benefit from RME/FM therapy. The webinar concludes by presenting findings from a recent Consensus Conference comparing bone-anchored devices with conventionally anchored appliances for Class III correction, addressing a persistent debate regarding treatment efficacy and stability.

This event appeals to orthodontists, residents in orthodontic programs, and general practitioners managing Class III patients. Participants will gain evidence-based knowledge to optimize treatment selection, predict growth patterns, and improve long-term stability outcomes in early Class III cases.

This webinar delivers current evidence on early Class III treatment stability, a fundamental concern for every orthodontist managing growing patients. You will learn how artificial intelligence can predict craniofacial growth patterns, giving you concrete tools to improve treatment planning and patient counseling.

The presentation addresses critical clinical questions about RME/FM therapy longevity, mandibular growth control, and the comparative effectiveness of bone-anchored versus conventional devices. Treatment timing represents another major learning focus, with data showing how prepubertal versus pubertal initiation affects long-term outcomes.

Findings from a recent Consensus Conference on device anchoring methods provide current best-practice guidance. One hour of focused continuing education covers multiple aspects of Class III treatment strategy, offering immediate clinical application for your practice.